Skip to main content

GSK

GSK plc is a British biopharmaceutical enterprise that discovers, develops, and manufactures specialty medicines and vaccines globally. The company concentrates its operational activities across three core therapeutic product areas: Vaccines, Specialty Medicines, and General Medicines. Its key commercial product portfolio includes innovative vaccines such as Shingrix for shingles and Arexvy for RSV, alongside prescription medicines for HIV, oncology, respiratory, and infectious diseases. Principal revenue drivers consist of commercial sales of proprietary vaccines and prescription pharmaceuticals, supplemented by royalty revenues and strategic product licensing partnerships. GSK serves broad global end markets encompassing hospital procurement groups, government immunization programs, retail pharmacies, healthcare providers, and patients across North America, Europe, and international markets. The corporation holds a leading market position as one of the world's largest vaccine manufacturers and biopharmaceutical companies by research investment and annual revenues. Headquartered in London, United Kingdom, the company's common stock is primary listed on the London Stock Exchange under the ticker symbol GSK, with American Depositary Receipts listed on the New York Stock Exchange.

131 of the funds FundTelligence covers report a position in GSK.

Legal name
GSK PLC
Sector
Health Care
Country
United Kingdom
Funds holding it
131
Exposure themes
Multiple, Treatment, Women's Health

Funds holding GSK

Showing the 8 largest of 131 funds holding it.

Loading...